Clinical trial
Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With…
NCT00004176 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00004176 |
|---|---|
| Title | Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer |
| Official title | A Phase II Evaluation of Ethyol as an Esophageal Mucosal Protectant in the Treatment of Limited Disease Small Cell Lung Cancer With Chemotherapy and Twice-Daily Radiation |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Radiation Toxicity |
| Intervention type | Drug, Radiation |
| Interventions | amifostine trihydrate, cisplatin, etoposide, radiation therapy |
| Enrollment | 34 |
| Start date | Oct 1, 1998 |
| Primary completion | Feb 1, 2001 |
| Completion | Feb 1, 2001 |
| First posted | May 25, 2004 |
| Last update posted | May 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: